{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-001304","form_type":"8-K","ticker":"PTGX","cik":"0001377121","company_name":"Protagonist Therapeutics, Inc","filed_at":"2025-01-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.471690+00:00","generated_at":"2026-05-28T10:01:59.425831+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Protagonist Therapeutics appoints Suneel Gupta as EVP, Clinical Development","bullets":["Effective Jan 1, 2025, Suneel Gupta transitioned from Chief Development Officer to EVP, Clinical Development.","Gupta, previously CDO, now serves as Executive Vice President, Clinical Development.","No other officer changes were reported in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-001304","json":"https://secwatch.observer/filing/0001104659-25-001304.json","markdown":"https://secwatch.observer/filing/0001104659-25-001304.md","text":"https://secwatch.observer/filing/0001104659-25-001304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/0001104659-25-001304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/tm251959d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T10:01:59.425831+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6527c83d83","claim":"Suneel Gupta changed role as Executive Vice President, Clinical Development at Protagonist Therapeutics, Inc.","evidence_excerpt":"Effective January 1, 2025, Suneel Gupta, Ph.D., Protagonist Therapeutics, Inc.’s Chief Development Officer, transitioned to Executive Vice President, Clinical Development.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001304/0001104659-25-001304-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"transitioned"},{"label":"Role","value":"Executive Vice President, Clinical Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}